For this article:

2 Feb 2026·Source: The Indian Express
4 min
Science & TechnologySocial IssuesSocial IssuesNEWS

3D Lung Model Enhances Tuberculosis Drug Testing Efficiency

Cutting-edge research at IISc, Bengaluru, uses 3D lung model for TB drug testing.

UPSC●SSC
3D Lung Model Enhances Tuberculosis Drug Testing Efficiency

Photo by CDC

Quick Revision

1.

IISc Bengaluru: Developing 3D lung model for TB drug testing

Visual Insights

Location of Indian Institute of Science (IISc)

This map shows the location of the Indian Institute of Science (IISc) in Bengaluru, where the 3D lung model for TB drug testing is being developed.

Loading interactive map...

📍Karnataka

Exam Angles

1.

GS Paper III: Science and Technology - Developments and their applications and effects in everyday life

2.

GS Paper II: Health - Issues relating to development and management of Social Sector/Services relating to Health

3.

Potential question types: Statement-based, analytical questions on drug development and testing methodologies

View Detailed Summary

Summary

Researchers at the Indian Institute of Science (IISc), Bengaluru, are using a cutting-edge 3D model of the human lung to improve the testing of drugs for tuberculosis (TB). This innovative approach allows for a more accurate and efficient assessment of how TB drugs behave within the complex environment of the lung.

The 3D lung model mimics the structure and function of the human lung, providing a more realistic testing ground compared to traditional methods. This advancement is expected to accelerate the development of new and more effective treatments for TB.

Background

The development of in-vitro models for drug testing has a rich history, evolving from simple cell cultures to complex 3D structures. Early drug testing relied heavily on animal models, which often failed to accurately predict human responses due to physiological differences. This led to the exploration of cell-based assays, initially using 2D cell cultures. However, these 2D models lacked the complexity of the in-vivo environment, prompting the development of more sophisticated 3D models. The transition to 3D models marked a significant advancement. These models, including spheroids and organoids, better mimic the cellular interactions and microenvironment found in living tissues. The use of biomaterials and advanced cell culture techniques enabled researchers to create structures that more closely resemble the architecture and function of organs. This evolution has been driven by the need for more accurate and reliable drug testing methods, reducing the reliance on animal testing and accelerating the drug development process. Regulatory frameworks, such as those established by the FDA (Food and Drug Administration) and the EMA (European Medicines Agency), are increasingly recognizing the value of in-vitro models in drug development. These agencies are encouraging the use of advanced in-vitro models to improve the efficiency and accuracy of drug testing, potentially reducing the time and cost associated with bringing new drugs to market. The development of the 3D lung model by IISc aligns with this trend, offering a more physiologically relevant platform for testing TB drugs.

Latest Developments

Recent advancements in drug testing methodologies include the integration of artificial intelligence (AI) and machine learning (ML) to analyze large datasets generated from in-vitro and in-vivo studies. These technologies can help identify potential drug candidates and predict their efficacy and toxicity with greater accuracy. The use of organ-on-a-chip technology, which combines microfluidics and cell culture, is also gaining traction, allowing for the creation of highly controlled and physiologically relevant microenvironments for drug testing. Ongoing debates in the field of drug development revolve around the ethical considerations of animal testing and the need for more predictive human-relevant models. There is a growing consensus that advanced in-vitro models, such as the 3D lung model developed by IISc, can play a crucial role in reducing the reliance on animal testing and improving the success rate of clinical trials. Institutions like the Council of Scientific and Industrial Research (CSIR) are actively promoting the development and validation of alternative testing methods. The future outlook for drug testing involves the development of personalized medicine approaches, where drug treatments are tailored to individual patients based on their genetic and physiological characteristics. This will require the use of sophisticated in-vitro models that can accurately replicate the patient's specific disease state and predict their response to different drugs. The integration of genomics, proteomics, and other omics technologies will further enhance the predictive power of these models, paving the way for more effective and targeted therapies.

Frequently Asked Questions

1. What is the main purpose of the 3D lung model developed by IISc Bengaluru, and why is it important?

The 3D lung model developed by IISc Bengaluru is primarily for improving the testing of drugs for tuberculosis (TB). It's important because it provides a more accurate and efficient way to assess how TB drugs behave within the lung's complex environment, potentially accelerating the development of new treatments.

2. How does the 3D lung model enhance TB drug testing compared to traditional methods?

The 3D lung model mimics the structure and function of the human lung, offering a more realistic testing environment than traditional methods like 2D cell cultures or animal models. This leads to a more accurate assessment of drug behavior and potential efficacy.

3. What are the key facts about the 3D lung model for UPSC Prelims?

For UPSC Prelims, remember that the Indian Institute of Science (IISc), Bengaluru, is developing a 3D lung model for TB drug testing. Focus on the institution involved and the purpose of the model.

4. Why is the development of a 3D lung model for TB drug testing considered a significant advancement?

It is significant because traditional drug testing methods often fail to accurately predict how drugs will behave in the human lung. The 3D model offers a more realistic environment, potentially leading to the development of more effective TB treatments and reducing the reliance on animal models.

5. How might this 3D lung model impact common citizens?

If the 3D lung model accelerates the development of more effective TB drugs, it could lead to better treatment outcomes, reduced transmission rates, and improved public health overall. This is especially important in regions where TB is prevalent.

6. What are the recent developments related to drug testing methodologies, as mentioned in the background context?

Recent advancements include the integration of artificial intelligence (AI) and machine learning (ML) to analyze data from drug testing, and the use of organ-on-a-chip technology, which combines microfluidics and cell cultures to mimic organ functions.

7. What is 'organ-on-a-chip' technology, and how is it relevant to the 3D lung model?

Organ-on-a-chip technology combines microfluidics and cell cultures to mimic the functions of organs. It's relevant because the 3D lung model could potentially be integrated with organ-on-a-chip technology for even more realistic and comprehensive drug testing.

8. What are the potential drawbacks or limitations of relying solely on in-vitro models like the 3D lung model for drug testing?

While in-vitro models offer advantages, they may not fully replicate the complexity of the human body, including immune responses and interactions with other organs. Therefore, results from 3D lung models need to be validated with further studies.

9. Why is this topic in the news recently?

This topic is in the news due to the recent advancements made by researchers at the Indian Institute of Science (IISc), Bengaluru, in developing and using a 3D model of the human lung to improve TB drug testing efficiency.

10. For UPSC Mains, how can I use the information about the 3D lung model in an answer related to healthcare or science and technology?

In a Mains answer, you can cite the 3D lung model as an example of innovative approaches to drug discovery and testing, highlighting its potential to accelerate the development of treatments for diseases like tuberculosis. You can also discuss the broader implications for reducing reliance on animal models and improving the efficiency of pharmaceutical research.

Practice Questions (MCQs)

1. Consider the following statements regarding the 3D lung model developed by the Indian Institute of Science (IISc), Bengaluru: 1. It is used to improve the testing of drugs for HIV. 2. It mimics the structure and function of the human lung, providing a more realistic testing environment. 3. It is expected to slow down the development of new treatments for Tuberculosis (TB). Which of the statements given above is/are correct?

  • A.1 only
  • B.2 only
  • C.1 and 3 only
  • D.1, 2 and 3
Show Answer

Answer: B

Statement 1 is INCORRECT: The 3D lung model is used for testing drugs for Tuberculosis (TB), not HIV. Statement 2 is CORRECT: The model mimics the structure and function of the human lung, providing a more realistic testing environment compared to traditional methods. Statement 3 is INCORRECT: The 3D lung model is expected to accelerate the development of new treatments for TB, not slow it down. Therefore, only statement 2 is correct.

2. Which of the following best describes the primary advantage of using a 3D lung model for tuberculosis (TB) drug testing, as opposed to traditional 2D cell cultures?

  • A.Reduced cost of testing
  • B.Faster drug screening process
  • C.More accurate assessment of drug behavior within the complex lung environment
  • D.Elimination of the need for animal testing
Show Answer

Answer: C

The primary advantage of using a 3D lung model is that it allows for a more accurate assessment of drug behavior within the complex environment of the lung. This is because the 3D model mimics the structure and function of the human lung, providing a more realistic testing ground compared to traditional 2D cell cultures. While the 3D model may contribute to faster screening and reduced animal testing, the most significant benefit is the improved accuracy in predicting drug efficacy.

3. Assertion (A): The 3D lung model developed by IISc Bengaluru is expected to accelerate the development of new and more effective treatments for TB. Reason (R): The 3D lung model provides a more realistic testing ground compared to traditional methods, allowing for a more accurate and efficient assessment of how TB drugs behave within the complex environment of the lung. In the context of the above, which of the following is correct?

  • A.Both A and R are true and R is the correct explanation of A
  • B.Both A and R are true but R is NOT the correct explanation of A
  • C.A is true but R is false
  • D.A is false but R is true
Show Answer

Answer: A

Both the assertion and the reason are true, and the reason correctly explains the assertion. The 3D lung model's ability to mimic the lung environment accurately leads to a more efficient and accurate assessment of TB drugs, which in turn accelerates the development of new treatments.